产前超声能否预测SARS-CoV-2感染孕妇的不良新生儿结局?
该前瞻性观察队列纳入2020年3月至2021年5月经逆转录聚合酶链反应确诊SARS-CoV-2感染的孕妇,感染后至少行一次产前超声评估。100例中92例有新生儿结局(97名婴儿),28例(29%)发生复合不良新生儿结局,23例(23%)至少一项产前超声异常;胎儿生长受限与复合不良新生儿结局相关(校正比值比22.67,95%CI 2.63-194.91,P<.001)。
要点
- 感染后产前超声异常以胎盘增大(11/23,47.8%)和胎儿生长受限(8/23,34.8%)最常见。
- 胎儿生长受限与复合不良新生儿结局相关(25% vs 1.5%;校正比值比22.67,95%CI 2.63-194.91,P<.001)。
- 作者认为SARS-CoV-2感染后出现胎儿生长受限的妊娠可能需要密切监测。
核心结论
- 本研究中胎儿生长受限发生率与一般人群相当,但复合不良新生儿结局发生率较高。
- SARS-CoV-2感染后出现胎儿生长受限的妊娠与不良新生儿结局风险增加相关,可能需要密切监测。
研究设计与样本
- 前瞻性观察队列研究,纳入2020年3月至2021年5月经逆转录聚合酶链反应确诊SARS-CoV-2感染的孕妇。
- 感染后至少行一次产前超声评估,测量标准胎儿生物测量、脐动脉及大脑中动脉多普勒、胎盘厚度、羊水量及感染相关解剖筛查。
- 共识别103例有产前超声评估的SARS-CoV-2感染母婴对,排除3例已知重大胎儿畸形,纳入100例;92例妊娠(97名婴儿)有新生儿结局数据。
主要发现
- 92例妊娠中28例(29%)发生复合不良新生儿结局,23例(23%)至少一项产前超声异常。
- 超声异常中最常见为胎盘增大(11/23,47.8%)和胎儿生长受限(8/23,34.8%)。
- 胎儿生长受限与复合不良新生儿结局相关(25% vs 1.5%;校正比值比22.67,95%CI 2.63-194.91;P<.001),即使从复合结局中移除小于胎龄儿仍存在。
- 控制可能胎儿生长受限混杂因素的Cochran Mantel-Haenszel检验仍显示该关联(相对危险度3.7,95%CI 2.6-5.9;P<.001)。
- 复合不良新生儿结局组中位估计胎儿体重及出生体重更低(P<.001);妊娠晚期感染与估计胎儿体重中位百分位更低相关(P=.019);胎盘增大与妊娠晚期SARS-CoV-2感染相关(P=.045)。
关键数值与推荐
- 主要结局为复合不良新生儿结局,定义为以下至少一项:早产、新生儿重症监护病房入住、小于胎龄儿、呼吸窘迫、宫内胎儿死亡、新生儿死亡或其他新生儿并发症。
- 胎儿生长受限与复合不良新生儿结局的校正比值比22.67(95%CI 2.63-194.91;P<.001)。
- 控制混杂因素后相对危险度3.7(95%CI 2.6-5.9;P<.001)。
临床怎么用
- 作者认为SARS-CoV-2感染后出现胎儿生长受限的妊娠可能需要密切监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: On the basis of available data, at least 1 ultrasound assessment of pregnancies recovering from SARS-CoV-2 infection is recommended. However, reports on prenatal imaging findings and potential associations with neonatal outcomes following SARS-CoV-2 infection in pregnancy have been inconclusive. OBJECTIVE: This study aimed to describe the sonographic characteristics of pregnancies after confirmed SARS-CoV-2 infection and assess the association of prenatal ultrasound findings with adverse neonatal outcomes. STUDY DESIGN: This was an observational prospective cohort study of pregnancies diagnosed with SARS-CoV-2 by reverse transcription polymerase chain reaction between March 2020 and May 2021. Prenatal ultrasound evaluation was performed at least once after diagnosis of infection, with the following parameters measured: standard fetal biometric measurements, umbilical and middle cerebral artery Dopplers, placental thickness, amniotic fluid volume, and anatomic survey for infection-associated findings. The primary outcome was the composite adverse neonatal outcome, defined as ≥1 of the following: preterm birth, neonatal intensive care unit admission, small for gestational age, respiratory distress, intrauterine fetal demise, neonatal demise, or other neonatal complications. Secondary outcomes were sonographic findings stratified by trimester of infection and severity of SARS-CoV-2 infection. Prenatal ultrasound findings were compared with neonatal outcomes, severity of infection, and trimester of infection. RESULTS: A total of 103 SARS-CoV-2-affected mother-infant pairs with prenatal ultrasound evaluation were identified; 3 cases were excluded because of known major fetal anomalies. Of the 100 included cases, neonatal outcomes were available in 92 pregnancies (97 infants); of these, 28 (29%) had the composite adverse neonatal outcome, and 23 (23%) had at least 1 abnormal prenatal ultrasound finding. The most common abnormalities seen on ultrasound were placentomegaly (11/23; 47.8%) and fetal growth restriction (8/23; 34.8%). The latter was associated with a higher rate of the composite adverse neonatal outcome (25% vs 1.5%; adjusted odds ratio, 22.67; 95% confidence interval, 2.63-194.91; P<.001), even when small for gestational age was removed from this composite outcome. The Cochran Mantel-Haenszel test controlling for possible fetal growth restriction confounders continued to show this association (relative risk, 3.7; 95% confidence interval, 2.6-5.9; P<.001). Median estimated fetal weight and birthweight were lower in patients with the composite adverse neonatal outcome (P<.001). Infection in the third trimester was associated with lower median percentile of estimated fetal weight (P=.019). An association between placentomegaly and third-trimester SARS-CoV-2 infection was noted (P=.045). CONCLUSION: In our study of SARS-CoV-2-affected maternal-infant pairs, rates of fetal growth restriction were comparable to those found in the general population. However, composite adverse neonatal outcome rates were high. Pregnancies with fetal growth restriction after SARS-CoV-2 infection were associated with an increased risk for the adverse neonatal outcome and may require close surveillance.
引用
- Mei JY, Mok T, Cambou MC, et al. Can prenatal ultrasound predict adverse neonatal outcomes in SARS-CoV-2-affected pregnancies? Am J Obstet Gynecol MFM. 2023. PMID: 37295718. doi:10.1016/j.ajogmf.2023.101028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。